Lipe & Dalton trimmed its position in AbbVie Inc. ( NYSE:ABBV – Free Report ) by 3.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,010 shares of the company's stock after selling 1,499 shares during the quarter. AbbVie accounts for 3.7% of Lipe & Dalton's portfolio, making the stock its 4th largest position. Lipe & Dalton's holdings in AbbVie were worth $6,376,000 at the end of the most recent reporting period.

https://www.dailypolitical.com/2023/07/23/abbvie-inc-nyseabbv-shares-sold-by-lipe-dalton.html

#dailypolitical